Antivirals for Influenza
Antiviral guidance summary can be found HERE
- All patients admitted to hospital with influenza are regarded as 'complicated' and should be commenced on antiviral ASAP
- Antiviral prophylaxis should be offered to all hospitalised patients exposed to symptomatic influenza cases e.g. bay contact
- Patients with influenza who have completed 5 days of antiviral treatment no longer require isolation & enhanced infection control precautions
At-risk groups eligible for antiviral treatment for uncomplicated influenza when admission not required:
- Neurological, hepatic, renal, pulmonary and chronic cardiac disease
- Diabetes mellitus
- Severe immunosuppression
- Age over 65 years
- Pregnancy (including up to 2 weeks post-partum)
- Children under 6 months of age
- Morbid obesity (BMI ≥40)
(adapted from UKHSA Guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenza Version 11, November 2021)